Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s
Clinical trial NCT03457597 · COMPLETED
Trial details
- NCT number
- NCT03457597
- Sponsor
- Corcept Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-06
- Primary completion
- 2018-04-15
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.